Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
6.48
+0.26 (4.18%)
Aug 20, 2026, 3:04 PM CST
SHE:002107 Revenue
Shandong Wohua Pharmaceutical had revenue of 174.30M CNY in the quarter ending June 30, 2026, a decrease of -16.01%. This brings the company's revenue in the last twelve months to 784.94M, down -1.14% year-over-year. In the year 2025, Shandong Wohua Pharmaceutical had annual revenue of 816.95M with 6.96% growth.
Revenue (ttm)
784.94M
Revenue Growth
-1.14%
P/S Ratio
4.77
Revenue / Employee
771.06K
Employees
1,018
Market Cap
3.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.95M | 53.16M | 6.96% |
| Dec 31, 2024 | 763.79M | -145.71M | -16.02% |
| Dec 31, 2023 | 909.51M | -105.31M | -10.38% |
| Jan 1, 2023 | 1.01B | 72.14M | 7.65% |
| Jan 1, 2022 | 942.67M | -63.41M | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.47B |
| Nanjing Well Pharmaceutical Group | 1.34B |
| Huaren Pharmaceutical | 1.33B |
| PKU HealthCare Corp.,Ltd. | 1.20B |
| Zhejiang Cheng Yi Pharmaceutical | 827.75M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 543.82M |
| Shaanxi Kanghui Pharmaceutical | 443.29M |
| Guangdong Lifestrong Pharmacy | 310.01M |